Vencanna Ventures Stock Price, News & Analysis
Company Description
Vencanna Ventures (OTC: TPPRF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $8.5M.
TPPRF stock has gained 22.3% over the past year.
This page provides a comprehensive overview of TPPRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vencanna Ventures (TPPRF) stock. Over the past 12 months, the stock has gained 22.3%. At a market capitalization of $8.5M, TPPRF is classified as a micro-cap stock with approximately 182.0M shares outstanding.
Latest News
Vencanna Ventures has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include earnings. View all TPPRF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TPPRF Company Profile & Sector Positioning
Vencanna Ventures (TPPRF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TPPRF often look at related companies in the same sector, including (CANBD), (GENH), Evoke Pharma Inc (EVOK), Biofrontera Inc (BFRI), and Im Cannabis Corp (IMCC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TPPRF's relative position within its industry.